We are live on ! Find out more
NA

NewEdge Advisors Portfolio holdings

AUM $27.7B
1-Year Est. Return 22.98%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+22.98%
3 Year Est. Return
+69.07%
5 Year Est. Return
+86.55%
10 Year Est. Return
+264.51%
AUM
$19.4B
AUM Growth
+$2.56B
Cap. Flow
+$928M
Cap. Flow %
4.78%
Top 10 Hldgs %
18.4%
Holding
4,199
New
245
Increased
1,651
Reduced
1,242
Closed
214

Sector Composition

Rank Sector Weight
1 Technology 14.96%
2 Financials 7.01%
3 Consumer Discretionary 4.43%
4 Healthcare 3.73%
5 Communication Services 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNMD icon
3901
CONMED
CNMD
$1.41B
$104 ﹤0.01%
2
-10
-83% -$549
VIR icon
3902
Vir Biotechnology
VIR
$1.5B
$101 ﹤0.01%
20
HDGE icon
3903
AdvisorShares Ranger Equity Bear ETF
HDGE
$59.8M
$100 ﹤0.01%
6
OMEX icon
3904
Odyssey Marine Exploration
OMEX
$37.9M
$99 ﹤0.01%
84
BBC icon
3905
Virtus Biotech Clinical Trials ETF
BBC
$47.8M
$97 ﹤0.01%
5
ESQ icon
3906
Esquire Financial Holdings
ESQ
$1.12B
$96 ﹤0.01%
1
GWH icon
3907
ESS Tech
GWH
$22.3M
$95 ﹤0.01%
72
BIVI icon
3908
BioVie
BIVI
$10.8M
$93 ﹤0.01%
10
-5,400
-100% -$53.3K
ANGI icon
3909
Angi Inc
ANGI
$229M
$92 ﹤0.01%
+6
New +$87
WGS icon
3910
GeneDx Holdings
WGS
$2.05B
$92 ﹤0.01%
1
-2,707
-100% -$213K
DTIL icon
3911
Precision BioSciences
DTIL
$181M
$91 ﹤0.01%
22
LESL icon
3912
Leslie's
LESL
$8.12M
$91 ﹤0.01%
11
USDU icon
3913
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$455M
$86 ﹤0.01%
3
LLYVK icon
3914
Liberty Live Group Series C
LLYVK
$9.72B
$81 ﹤0.01%
1
CBL
3915
CBL Properties
CBL
$1.8B
$76 ﹤0.01%
+3
New +$74
MBIN icon
3916
Merchants Bancorp
MBIN
$2.55B
$66 ﹤0.01%
2
-606
-100% -$19.6K
CION icon
3917
CION Investment
CION
$294M
$64 ﹤0.01%
7
+1
+17% +$10
KPRX icon
3918
Kiora Pharmaceuticals
KPRX
$11.3M
$63 ﹤0.01%
22
XFOR icon
3919
X4 Pharmaceuticals
XFOR
$377M
$63 ﹤0.01%
33
CARZ icon
3920
First Trust Exchange-Traded Fund II First Trust S-Network Future Vehicles & Technology ETF
CARZ
$46.1M
$62 ﹤0.01%
1
BNT
3921
Brookfield Wealth Solutions
BNT
$11.7B
$62 ﹤0.01%
2
CVM icon
3922
CEL-SCI Corp
CVM
$21.3M
$60 ﹤0.01%
26
-1
-4% -$5
BTAI icon
3923
BioXcel Therapeutics
BTAI
$24.5M
$57 ﹤0.01%
31
CODX
3924
Co-Diagnostics
CODX
$5.75M
$56 ﹤0.01%
7
CRBP icon
3925
Corbus Pharmaceuticals
CRBP
$168M
$55 ﹤0.01%
8
-1
-11% -$7

Similar funds

NewEdge Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, NewEdge Advisors held 4,199 positions worth $19.4B, up 15% from $16.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

NewEdge Advisors deployed $928M of net new capital in Q2 2025, opening 245 new positions and adding to 1,651 existing holdings. Its largest new stake was Capital Group New Geography Equity ETF: 576,180 shares worth $16.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $127M trimmed.

  • NewEdge Advisors's largest Q2 2025 buy was Capital Group New Geography Equity ETF: 576,180 shares worth $16.6M.
  • NewEdge Advisors added most to iShares U.S. Thematic Rotation Active ETF in Q2 2025, an estimated $63.4M increase.
  • NewEdge Advisors's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $127M.
  • NewEdge Advisors fully exited Vanguard US Value Factor ETF in Q2 2025, selling an estimated $4.61M.
  • NewEdge Advisors's ten largest holdings make up 18% of its $19.4B portfolio in Q2 2025.
  • NewEdge Advisors opened 245 new positions and closed 214 in Q2 2025.
  • NewEdge Advisors's portfolio value rose 15% quarter-over-quarter to $19.4B.

Based on NewEdge Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.